BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38224387)

  • 1. Analysis of Breast Cancer Screening Results and Influencing Factors of Breast Cancer in Guangdong Province from 2017 to 2021.
    Wu L; Chen GZ; Zeng ZR; Ji CW; Zhang AQ; Xia JH; Liu GC
    J Epidemiol Glob Health; 2024 Mar; 14(1):131-141. PubMed ID: 38224387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of screening mammography among women with and without a first-degree relative with breast cancer.
    Kerlikowske K; Carney PA; Geller B; Mandelson MT; Taplin SH; Malvin K; Ernster V; Urban N; Cutter G; Rosenberg R; Ballard-Barbash R
    Ann Intern Med; 2000 Dec; 133(11):855-63. PubMed ID: 11103055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of breast cancer cases according to county-level poverty status in 3.5 million rural women who participated in a breast cancer screening program of Hunan province, China from 2016 to 2018.
    Lili X; Zhiyu L; Yinglan W; Aihua W; Hongyun L; Ting L; Yingxia W; Guanghui Y; Xianghua C; Junqun F; Donghua X; Fanjuan K
    Medicine (Baltimore); 2020 Apr; 99(17):e19954. PubMed ID: 32332679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis for the breast cancer screening among urban populations in China, 2012-2013].
    Mi ZH; Ren JS; Zhang HZ; Li J; Wang Y; Fang Y; Shi JF; Zhang K; Zhao JB; Dai M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Oct; 50(10):887-892. PubMed ID: 27686767
    [No Abstract]   [Full Text] [Related]  

  • 5. Breast Cancer Screening in High-Risk Men: A 12-year Longitudinal Observational Study of Male Breast Imaging Utilization and Outcomes.
    Gao Y; Goldberg JE; Young TK; Babb JS; Moy L; Heller SL
    Radiology; 2019 Nov; 293(2):282-291. PubMed ID: 31526252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interval breast cancers in the 'screening with tomosynthesis or standard mammography' (STORM) population-based trial.
    Houssami N; Bernardi D; Caumo F; Brunelli S; Fantò C; Valentini M; Romanucci G; Gentilini MA; Zorzi M; Macaskill P
    Breast; 2018 Apr; 38():150-153. PubMed ID: 29328943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the coverage of cervical and breast cancer screening among women aged 35-69 years and related impact of socioeconomic factors in China, 2013].
    Bao HL; Wang LH; Wang LM; Fang LW; Zhang M; Zhao ZP; Cong S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):208-212. PubMed ID: 29495207
    [No Abstract]   [Full Text] [Related]  

  • 8. Emerging Trends in Family History of Breast Cancer and Associated Risk.
    Shiyanbola OO; Arao RF; Miglioretti DL; Sprague BL; Hampton JM; Stout NK; Kerlikowske K; Braithwaite D; Buist DSM; Egan KM; Newcomb PA; Trentham-Dietz A
    Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1753-1760. PubMed ID: 28986348
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors Associated with False Positive Results on Screening Mammography in a Population of Predominantly Hispanic Women.
    McGuinness JE; Ueng W; Trivedi MS; Yi HS; David R; Vanegas A; Vargas J; Sandoval R; Kukafka R; Crew KD
    Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):446-453. PubMed ID: 29382701
    [No Abstract]   [Full Text] [Related]  

  • 10. Social Determinants of Breast Cancer Screening among Married Women: A Cross-Sectional Study.
    Ghanbari A; Rahmatpour P; Hosseini N; Khalili M
    J Res Health Sci; 2020 Feb; 20(1):e00467. PubMed ID: 32814688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?
    Taplin SH; Ichikawa L; Yood MU; Manos MM; Geiger AM; Weinmann S; Gilbert J; Mouchawar J; Leyden WA; Altaras R; Beverly RK; Casso D; Westbrook EO; Bischoff K; Zapka JG; Barlow WE
    J Natl Cancer Inst; 2004 Oct; 96(20):1518-27. PubMed ID: 15494602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk.
    Lee JM; Arao RF; Sprague BL; Kerlikowske K; Lehman CD; Smith RA; Henderson LM; Rauscher GH; Miglioretti DL
    JAMA Intern Med; 2019 May; 179(5):658-667. PubMed ID: 30882843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening Performance of Digital Breast Tomosynthesis vs Digital Mammography in Community Practice by Patient Age, Screening Round, and Breast Density.
    Lowry KP; Coley RY; Miglioretti DL; Kerlikowske K; Henderson LM; Onega T; Sprague BL; Lee JM; Herschorn S; Tosteson ANA; Rauscher G; Lee CI
    JAMA Netw Open; 2020 Jul; 3(7):e2011792. PubMed ID: 32721031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in breast cancer risk distribution among Vermont women using screening mammography.
    Bolton KC; Mace JL; Vacek PM; Herschorn SD; James TA; Tice JA; Kerlikowske K; Geller BM; Weaver DL; Sprague BL
    J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 24957223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
    Mouchawar J; Taplin S; Ichikawa L; Barlow WE; Geiger AM; Weinmann S; Gilbert J; Manos MM; Ulcickas Yood M
    J Natl Cancer Inst Monogr; 2005; (35):39-46. PubMed ID: 16287884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
    Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
    JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
    Vreemann S; van Zelst JCM; Schlooz-Vries M; Bult P; Hoogerbrugge N; Karssemeijer N; Gubern-Mérida A; Mann RM
    Breast Cancer Res; 2018 Aug; 20(1):84. PubMed ID: 30075794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible logistic and sociodemographyc factors on breast cancer screening in Turkey: lessons from a women’s health project in Mersin province.
    Abali H; Ata A; Gokçe G; Gokçe H
    J Cancer Educ; 2012 Jun; 27(2):347-52. PubMed ID: 21976034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast Cancer Screening During the COVID-19 Pandemic in the United States: Results From Real-World Health Records Data.
    Chung A; Chen Q; Curry W; Felix T; Tuan WJ
    Ann Fam Med; 2024; 22(3):208-214. PubMed ID: 38806260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, Characteristics, and Outcomes of Interval Breast Cancers Compared With Screening-Detected Breast Cancers.
    Niraula S; Biswanger N; Hu P; Lambert P; Decker K
    JAMA Netw Open; 2020 Sep; 3(9):e2018179. PubMed ID: 32975573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.